{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:32:11Z","timestamp":1794954731307,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The risk of gastric cancer (GC) remains in precancerous conditions, including atrophic mucosa and intestinal mucosa (IM), even after\n                    <jats:italic>H<\/jats:italic>\n                    .\n                    <jats:italic>pylori<\/jats:italic>\n                    treatment. To define the molecular changes following\n                    <jats:italic>H<\/jats:italic>\n                    .\n                    <jats:italic>pylori<\/jats:italic>\n                    eradication, molecular alterations in the gastric mucosa with and without GC were evaluated in a long-term follow-up study. A total of 232 biopsy specimens from 78 consecutive patients, including atrophic gastritis patients with follow-up \u22653\u2009y after successful\n                    <jats:italic>H<\/jats:italic>\n                    .\n                    <jats:italic>pylori<\/jats:italic>\n                    eradication (AG group), patients who developed early GC after successful eradication (\u22653\u2009y) (GC group), and patients with\n                    <jats:italic>H<\/jats:italic>\n                    .\n                    <jats:italic>pylori<\/jats:italic>\n                    -positive atrophic gastritis (\n                    <jats:italic>Hp<\/jats:italic>\n                    group), were analyzed.\n                    <jats:italic>H<\/jats:italic>\n                    .\n                    <jats:italic>pylori<\/jats:italic>\n                    eradication was associated with significant reductions of methylation of several genes\/loci in atrophic mucosa (non-IM), but not in IM. In contrast, the incidence of CpG island methylator phenotype (CIMP) in IM was significantly higher in the GC group than in the AG group.\n                    <jats:italic>miR-124a-3<\/jats:italic>\n                    methylation and\n                    <jats:italic>miR-34c<\/jats:italic>\n                    methylation were more frequently identified in IM, with very few in non-IM mucosa among the three groups.\n                    <jats:italic>H<\/jats:italic>\n                    .\n                    <jats:italic>pylori<\/jats:italic>\n                    eradication can reverse methylation only in non-IM mucosa. CIMP in IM may have potential as a surrogate maker of GC development, and methylation of\n                    <jats:italic>miR-124a-3<\/jats:italic>\n                    and\n                    <jats:italic>miR-34c<\/jats:italic>\n                    is a molecular event in IM that may not be associated with GC development.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-32717-3","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T11:41:58Z","timestamp":1537357318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-term effects of H. pylori eradication on epigenetic alterations related to gastric carcinogenesis"],"prefix":"10.1038","volume":"8","author":[{"given":"Yuki","family":"Michigami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Watari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyomi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Tozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiron M.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Miwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"32717_CR1","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/00000478-199501000-00005","volume":"19","author":"P Correa","year":"1995","unstructured":"Correa, P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 19, S37\u2013S43 (1995).","journal-title":"Am J Surg Pathol."},{"key":"32717_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-013-0897-8","volume":"49","author":"M Asaka","year":"2014","unstructured":"Asaka, M., Kato, M. & Sakamoto, N. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan. J Gastroenterol. 49, 1\u20138 (2014).","journal-title":"J Gastroenterol."},{"key":"32717_CR3","unstructured":"International Agency for Research on Cancer. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC working group reports, vol 8. [Cited 2016\/12\/6]. http:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/wrk\/wrk8\/Helicobacter_pylori_Eradication.pdf."},{"key":"32717_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7326\/0003-4819-151-2-200907210-00009","volume":"151","author":"L Fuccio","year":"2009","unstructured":"Fuccio, L. et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 151, 121\u2013128 (2009).","journal-title":"Ann Intern Med."},{"key":"32717_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1053\/j.gastro.2016.01.028","volume":"150","author":"YC Lee","year":"2016","unstructured":"Lee, Y. C. et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 150, 1113\u20131124 (2016).","journal-title":"Gastroenterology."},{"key":"32717_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s00535-010-0347-9","volume":"46","author":"S Take","year":"2011","unstructured":"Take, S. et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol. 46, 318\u2013324 (2011).","journal-title":"J Gastroenterol."},{"key":"32717_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3109\/00365521.2013.838994","volume":"48","author":"M Kodama","year":"2013","unstructured":"Kodama, M. et al. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol. 48, 1249\u20131256 (2013).","journal-title":"Scand J Gastroenterol."},{"key":"32717_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-134-5-200103060-00010","volume":"134","author":"T Ohkusa","year":"2001","unstructured":"Ohkusa, T. et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med. 134, 380\u2013386 (2001).","journal-title":"Ann Intern Med."},{"key":"32717_CR9","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/gut.2005.072009","volume":"54","author":"R Mera","year":"2005","unstructured":"Mera, R. et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut. 54, 1536\u20131540 (2005).","journal-title":"Gut."},{"key":"32717_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s00535-011-0504-9","volume":"47","author":"M Kodama","year":"2012","unstructured":"Kodama, M. et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol. 47, 394\u2013403 (2012).","journal-title":"J Gastroenterol."},{"key":"32717_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/gut.52.4.502","volume":"52","author":"AO Chan","year":"2003","unstructured":"Chan, A. O. et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 52, 502\u2013506 (2003).","journal-title":"Gut."},{"key":"32717_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.LAB.0000067481.08984.3F","volume":"83","author":"GH Kang","year":"2003","unstructured":"Kang, G. H., Lee, S., Kim, J. S. & Jung, H. Y. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 83, 635\u2013641 (2003).","journal-title":"Lab Invest."},{"key":"32717_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/1078-0432.CCR-05-2096","volume":"12","author":"T Maekita","year":"2006","unstructured":"Maekita, T. et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 12, 989\u2013995 (2006).","journal-title":"Clin Cancer Res."},{"key":"32717_CR14","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1158\/1078-0432.CCR-05-2442","volume":"12","author":"WK Leung","year":"2006","unstructured":"Leung, W. K. et al. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res. 12, 3216\u20133221 (2006).","journal-title":"Clin Cancer Res."},{"key":"32717_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2005.077776","volume":"55","author":"AO Chan","year":"2006","unstructured":"Chan, A. O. et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut. 55, 463\u2013468 (2006).","journal-title":"Gut."},{"key":"32717_CR16","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1572-0241.2007.01284.x","volume":"102","author":"F Perri","year":"2007","unstructured":"Perri, F. et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol. 102, 1361\u20131371 (2007).","journal-title":"Am J Gastroenterol."},{"key":"32717_CR17","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/ijc.24219","volume":"124","author":"T Ando","year":"2009","unstructured":"Ando, T. et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer. 124, 2367\u20132374 (2009).","journal-title":"Int J Cancer."},{"key":"32717_CR18","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1053\/j.gastro.2009.12.042","volume":"138","author":"AR Sepulveda","year":"2010","unstructured":"Sepulveda, A. R. et al. CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection. Gastroenterology. 138, 1836\u20131844 (2010).","journal-title":"Gastroenterology."},{"key":"32717_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00535-009-0142-7","volume":"45","author":"T Nakajima","year":"2010","unstructured":"Nakajima, T. et al. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J Gastroenterol. 45, 37\u201344 (2010).","journal-title":"J Gastroenterol."},{"key":"32717_CR20","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ijc.23891","volume":"124","author":"CX Dong","year":"2009","unstructured":"Dong, C. X. et al. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int J Cancer. 124, 434\u2013439 (2009).","journal-title":"Int J Cancer."},{"key":"32717_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/carcin\/bgq259","volume":"32","author":"WQ Li","year":"2011","unstructured":"Li, W. Q. et al. RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population. Carcinogenesis. 32, 406\u2013410 (2011).","journal-title":"Carcinogenesis."},{"key":"32717_CR22","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.26275","volume":"130","author":"J Watari","year":"2012","unstructured":"Watari, J. et al. Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: an analysis of molecular pathology of Helicobacter pylori eradication. Int J Cancer. 130, 2349\u20132358 (2012).","journal-title":"Int J Cancer."},{"key":"32717_CR23","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/ijc.28219","volume":"133","author":"CM Shin","year":"2013","unstructured":"Shin, C. M. et al. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study. Int J Cancer. 133, 2034\u20132042 (2013).","journal-title":"Int J Cancer."},{"key":"32717_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/gutjnl-2014-307094","volume":"64","author":"K Asada","year":"2015","unstructured":"Asada, K. et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study. Gut. 64, 388\u2013396 (2015).","journal-title":"Gut."},{"key":"32717_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/bjc.2015.418","volume":"114","author":"M Kawanaka","year":"2016","unstructured":"Kawanaka, M. et al. Effects of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic treatment: analysis of molecular alterations by a randomised controlled trial. Br J Cancer. 114, 21\u201329 (2016).","journal-title":"Br J Cancer."},{"key":"32717_CR26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gutjnl-2016-313387","volume":"66","author":"M Maeda","year":"2017","unstructured":"Maeda, M. et al. High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study. Gut. 66, 1721\u20131723 (2017).","journal-title":"Gut."},{"key":"32717_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jcmgh.2017.02.003","volume":"3","author":"X Liu","year":"2017","unstructured":"Liu, X. & Meltzer, S. J. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol. 3, 348\u2013358 (2017).","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"32717_CR28","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/carcin\/bgq203","volume":"31","author":"H Suzuki","year":"2010","unstructured":"Suzuki, H. et al. Methylation-associated silencing of microRNA-34b\/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis. 31, 2066\u20132073 (2010).","journal-title":"Carcinogenesis."},{"key":"32717_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00535-013-0861-7","volume":"49","author":"R Suzuki","year":"2014","unstructured":"Suzuki, R. et al. Aberrant methylation of microRNA-34b\/c is a predictive marker of metachronous gastric cancer risk. J Gastroenterol. 49, 1135\u20131144 (2014).","journal-title":"J Gastroenterol."},{"key":"32717_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","volume":"372","author":"K Fukase","year":"2008","unstructured":"Fukase, K. et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randamised controlled trial. Lancet. 372, 392\u2013397 (2008).","journal-title":"Lancet."},{"key":"32717_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.gie.2011.08.030","volume":"75","author":"Y Maehata","year":"2012","unstructured":"Maehata, Y. et al. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc. 75, 39\u201346 (2012).","journal-title":"Gastrointest Endosc."},{"key":"32717_CR32","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1136\/gutjnl-2011-301647","volume":"62","author":"M Kato","year":"2013","unstructured":"Kato, M. et al. Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group. Gut. 62, 1425\u20131432 (2013).","journal-title":"Gut."},{"key":"32717_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/gut.52.6.807","volume":"52","author":"ZK Mirza","year":"2003","unstructured":"Mirza, Z. K. et al. Gastric intestinal metaplasia as detected by a novel biomarker is highly associated with gastric adenocarcinoma. Gut. 52, 807\u2013812 (2003).","journal-title":"Gut."},{"key":"32717_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cgh.2007.12.044","volume":"6","author":"J Watari","year":"2008","unstructured":"Watari, J. et al. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol. 6, 409\u2013417 (2008).","journal-title":"Clin Gastroenterol Hepatol."},{"key":"32717_CR35","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.3748\/wjg.v18.i36.5129","volume":"18","author":"JB Liu","year":"2012","unstructured":"Liu, J. B. et al. CpG island methylator phenotype and Helicobacter pylori infection associated with gastric cancer. World J Gastroenterol. 18, 5129\u20135134 (2012).","journal-title":"World J Gastroenterol."},{"key":"32717_CR36","doi-asserted-by":"publisher","first-page":"e86097","DOI":"10.1371\/journal.pone.0086097","volume":"9","author":"L Zong","year":"2014","unstructured":"Zong, L. & Seto, Y. CpG island methylator phenotype, Helicobacter pylori, Epstein-Barr virus, and microsatellite instability and prognosis in gastric cancer: a systematic review and meta-analysis. PLoS One. 9, e86097 (2014).","journal-title":"PLoS One."},{"key":"32717_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4253\/wjge.v2.i12.381","volume":"2","author":"S Enomoto","year":"2010","unstructured":"Enomoto, S. et al. Novel risk markers for gastric cancer screening: Present status and future prospects. World J Gastrointest Endosc. 2, 381\u2013387 (2010).","journal-title":"World J Gastrointest Endosc."},{"key":"32717_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s10120-016-0650-0","volume":"20","author":"M Maeda","year":"2017","unstructured":"Maeda, M., Moro, H. & Ushijima, T. Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway. Gastric Cancer. 20, 8\u201315 (2017).","journal-title":"Gastric Cancer."},{"key":"32717_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.canlet.2016.03.009","volume":"375","author":"Y Baba","year":"2016","unstructured":"Baba, Y. et al. Epigenetic field cancerization in gastrointestinal cancers. Cancer Lett. 375, 360\u2013366 (2016).","journal-title":"Cancer Lett."},{"key":"32717_CR40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1373\/clinchem.2008.121962","volume":"55","author":"LS Kristensen","year":"2009","unstructured":"Kristensen, L. S. & Hansen, L. L. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin Chem. 55, 1471\u20131483 (2009).","journal-title":"Clin Chem."},{"key":"32717_CR41","doi-asserted-by":"publisher","first-page":"e6708","DOI":"10.1097\/MD.0000000000006708","volume":"96","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Xin, S., Gao, M. & Cai, Y. Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis. Medicine (Baltimore). 96, e6708 (2017).","journal-title":"Medicine (Baltimore)."},{"key":"32717_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/jama.291.2.187","volume":"291","author":"BC Wong","year":"2004","unstructured":"Wong, B. C. et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 291, 187\u2013194 (2004).","journal-title":"JAMA."},{"key":"32717_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13842-x","volume":"7","author":"Y Michigami","year":"2017","unstructured":"Michigami, Y. et al. Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer. Sci Rep. 7, 13384 (2017).","journal-title":"Sci Rep."},{"key":"32717_CR44","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","volume":"71","author":"LG Capelle","year":"2010","unstructured":"Capelle, L. G. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 71, 1150\u20131158 (2010).","journal-title":"Gastrointest Endosc."},{"key":"32717_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ccell.2017.11.018","volume":"33","author":"KK Huang","year":"2018","unstructured":"Huang, K. K. et al. Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. Cancer Cell. 33, 137\u2013150 (2018).","journal-title":"Cancer Cell."},{"key":"32717_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","volume":"67","author":"KS Cheung","year":"2018","unstructured":"Cheung, K. S. et al. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 67, 28\u201335 (2018).","journal-title":"Gut."},{"key":"32717_CR47","doi-asserted-by":"publisher","unstructured":"Moayyedi, P. et al. Proton pump inhibitors and gastric cancer: association is not causation. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2018-316958. [Epub ahead of print] (2018)","DOI":"10.1136\/gutjnl-2018-316958."},{"key":"32717_CR48","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma \u2013 3rd English edition. Gastric Cancer. 14, 101\u2013112 (2011).","DOI":"10.1007\/s10120-011-0041-5"},{"key":"32717_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humpath.2016.09.022","volume":"60","author":"Y Nando","year":"2016","unstructured":"Nando, Y. et al. Genetic instability, CpG island methylator phenotype and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum. Hum Pathol. 60, 37\u201345 (2016).","journal-title":"Hum Pathol."},{"key":"32717_CR50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar, A. et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 96, 261\u2013268 (2004).","journal-title":"J Natl Cancer Inst."},{"key":"32717_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-012-0391-9","volume":"30","author":"M Bry\u015b","year":"2013","unstructured":"Bry\u015b, M. et al. Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers. Med Oncol. 30, 391 (2013).","journal-title":"Med Oncol."},{"key":"32717_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00432-015-2030-2","volume":"142","author":"T Eto","year":"2016","unstructured":"Eto, T. et al. Modal variety of microsatellite instability in human endometrial carcinomas. J Cancer Res Clin Oncol. 142, 353\u2013363 (2016).","journal-title":"J Cancer Res Clin Oncol."},{"key":"32717_CR53","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1002\/bjs.10742","volume":"105","author":"AGMT Powell","year":"2018","unstructured":"Powell, A. G. M. T., Soul, S., Christian, A. & Lewis, W. G. Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer. Br J Surg. 105, e61\u2013e68 (2018).","journal-title":"Br J Surg."},{"key":"32717_CR54","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrc1507","volume":"4","author":"JP Issa","year":"2004","unstructured":"Issa, J. P. CpG island methylator phenotype in cancer. Nat Rev Cancer. 4, 988\u2013993 (2004).","journal-title":"Nat Rev Cancer."},{"key":"32717_CR55","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/ng1834","volume":"38","author":"DJ Weisenberger","year":"2006","unstructured":"Weisenberger, D. J. et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 38, 787\u2013793 (2006).","journal-title":"Nat Genet."},{"key":"32717_CR56","first-page":"77","volume":"1825","author":"LA Hughes","year":"2012","unstructured":"Hughes, L. A. et al. The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta. 1825, 77\u201385 (2012).","journal-title":"Biochim Biophys Acta."},{"key":"32717_CR57","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1053\/j.gastro.2004.09.007","volume":"127","author":"A Rashid","year":"2004","unstructured":"Rashid, A. & Issa, J. P. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology. 127, 1578\u20131588 (2004).","journal-title":"Gastroenterology."},{"key":"32717_CR58","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/gast.2002.35392","volume":"123","author":"JR Jass","year":"2002","unstructured":"Jass, J. R., Whitehall, V. L. J., Young, J. & Leggett, B. A. Emerging concepts in colorectal neoplasia. Gastroenterology. 123, 862\u2013876 (2002).","journal-title":"Gastroenterology."},{"key":"32717_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00535-003-1260-2","volume":"39","author":"J Watari","year":"2004","unstructured":"Watari, J. et al. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype. J Gastroenterol. 39, 104\u2013112 (2004).","journal-title":"J Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32717-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32717-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:51:52Z","timestamp":1671598312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-32717-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["32717"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-32717-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14369"}}